Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-EN
Language English English
Date Updated 2020-08-21 2020-08-20
Drug Identification Number 02396874 02396874
Brand name TEVA-VORICONAZOLE TEVA-VORICONAZOLE
Common or Proper name VORICONAZOLE 200MG TAB VORICONAZOLE 200MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients VORICONAZOLE VORICONAZOLE
Strength(s) 200MG 200MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 30
ATC code J02AC J02AC
ATC description ANTIMYCOTICS FOR SYSTEMIC USE ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-07-15 2020-07-15
Estimated end date 2020-08-31 2020-08-31
Actual end date 2020-08-20 2020-08-20
Shortage status Resolved Actual shortage
Company comments
Health Canada comments